Synobody
Biotechnology ResearchView the employees at
Synobody-
Emil Arvedsen Co-founder of Synobody
-
Copenhagen, Capital Region, Denmark
-
Rising Star
-
Overview
Synobody increases accessibility of unique nanobodies for targeted therapeutics, diagnostics and research tools. Our platform is based on the largest and most cost-efficient synthetic nanobody library on the market thus allowing Synobody to reduce prices and turnaround time compared to competing options on the market.